INCR vs. TEVA

Last updated Jun 3, 2026

INCR (INC Research Holdings Inc) and TEVA (Teva Pharmaceutical Industries Limited) are both stocks. Both operate in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Over the past 3 years, INCR returned -18.89%/yr vs 65.59%/yr for TEVA. At a 0.17 correlation, their price movements are largely independent.

Performance

INCR vs. TEVA - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in INC Research Holdings Inc (INCR) and Teva Pharmaceutical Industries Limited (TEVA). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, INCR achieves a 13.19% return, which is significantly higher than TEVA's 5.19% return.

INCR

• 1D: -3.74%
• 1M: 16.04%
• YTD: 13.19%
• 6M: -21.97%
• 1Y: -35.22%
• 3Y*: -18.89%
• 5Y*: —
• 10Y*: —

TEVA

• 1D: -0.76%
• 1M: -7.13%
• YTD: 5.19%
• 6M: 17.97%
• 1Y: 90.98%
• 3Y*: 65.59%
• 5Y*: 25.85%
• 10Y*: -4.41%

*Multi-year figures are annualized to reflect compound growth (CAGR)

INCR vs. TEVA - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
INCR INC Research Holdings Inc	13.19%	-42.77%	23.27%	-60.92%	-49.07%	-4.00%
TEVA Teva Pharmaceutical Industries Limited	5.19%	41.61%	111.11%	14.47%	13.86%	-14.61%

Correlation

The correlation between INCR and TEVA is 0.03, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.03
Correlation (3Y) Calculated over the trailing 3-year period	0.11
Correlation (All Time) Calculated using the full available price history since Sep 2, 2021	0.18

The correlation between INCR and TEVA shifts across timeframes, from 0.03 (1 year) to 0.17 (all time), reflecting how their relationship changes across market environments.

Fundamentals

EPS INCR : -$1.25 TEVA : $1.34
PS Ratio INCR : 0.24 TEVA : 2.21
Total Revenue (TTM) INCR : $243.12M TEVA : $17.35B
Gross Profit (TTM) INCR : $40.61M TEVA : $9.03B
EBITDA (TTM) INCR : -$79.49M TEVA : $3.05B

Return for Risk

INCR vs. TEVA — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

INCR

INCR Risk / Return Rank: 16
INCR Sharpe Ratio Rank: 13
INCR Sortino Ratio Rank: 14
INCR Omega Ratio Rank: 16
INCR Calmar Ratio Rank: 19
INCR Martin Ratio Rank: 20

TEVA

TEVA Risk / Return Rank: 90
TEVA Sharpe Ratio Rank: 91
TEVA Sortino Ratio Rank: 92
TEVA Omega Ratio Rank: 91
TEVA Calmar Ratio Rank: 88
TEVA Martin Ratio Rank: 89

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

INCR vs. TEVA - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for INC Research Holdings Inc (INCR) and Teva Pharmaceutical Industries Limited (TEVA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	INCR	TEVA	Difference
Sharpe ratio Return per unit of total volatility	-0.65	2.37	-3.02
Sortino ratio Return per unit of downside risk	-0.81	3.54	-4.34
Omega ratio Gain probability vs. loss probability	0.91	1.45	-0.54
Calmar ratio Return relative to maximum drawdown	-0.59	4.20	-4.79
Martin ratio Return relative to average drawdown	-0.99	11.46	-12.46
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

INCR vs. TEVA - Sharpe Ratio Comparison

The current INCR Sharpe Ratio is -0.65, which is lower than the TEVA Sharpe Ratio of 2.37. The chart below compares the historical Sharpe Ratios of INCR and TEVA, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	INCR	TEVA	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.65	2.37	-3.02
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	—	0.61	—
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.09	—
Sharpe Ratio (All Time) Calculated using the full available price history	-0.51	0.31	-0.82

Drawdowns

INCR vs. TEVA - Drawdown Comparison

The maximum INCR drawdown since its inception was -91.57%, roughly equal to the maximum TEVA drawdown of -90.89%. Use the drawdown chart below to compare losses from any high point for INCR and TEVA.

Drawdown Indicators

	INCR	TEVA	Difference
Max Drawdown Largest peak-to-trough decline	-91.57%	-90.89%	-0.68%
Max Drawdown (1Y) Largest decline over 1 year	-57.80%	-21.79%	-36.01%
Max Drawdown (3Y) Largest decline over 3 years	-79.83%	-43.70%	-36.13%
Max Drawdown (5Y) Largest decline over 5 years	—	-43.70%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-88.41%	—
Current Drawdown Current decline from peak	-88.11%	-51.47%	-36.64%
Average Drawdown Average peak-to-trough decline	-65.35%	-31.99%	-33.36%
Ulcer Index Depth and duration of drawdowns from previous peaks	34.51%	7.96%	+26.55%

Volatility

INCR vs. TEVA - Volatility Comparison

INC Research Holdings Inc (INCR) has a higher volatility of 25.63% compared to Teva Pharmaceutical Industries Limited (TEVA) at 7.57%. This indicates that INCR's price experiences larger fluctuations and is considered to be riskier than TEVA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	INCR	TEVA	Difference
Volatility (1M) Calculated over the trailing 1-month period	25.63%	7.57%	+18.06%
Volatility (6M) Calculated over the trailing 6-month period	44.58%	23.20%	+21.38%
Volatility (1Y) Calculated over the trailing 1-year period	54.42%	38.67%	+15.75%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	64.83%	42.91%	+21.92%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	64.83%	47.30%	+17.53%

Dividends

INCR vs. TEVA - Dividend Comparison

Neither INCR nor TEVA has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
INCR INC Research Holdings Inc	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
TEVA Teva Pharmaceutical Industries Limited	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	3.88%	3.19%	1.77%

Financials

Frequently Asked Questions

Can I hold both INCR and TEVA in my portfolio?

INCR and TEVA have a correlation of 0.03, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, INCR or TEVA?

INCR has higher volatility (25.63%) compared to TEVA (7.57%). In terms of maximum drawdown, INCR dropped -91.57% vs TEVA's -90.89%.

Which has better risk-adjusted returns?

TEVA currently has the higher Sharpe Ratio (2.37 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.